Tokyo, Dec. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060168) titled 'Survey on How the Implementation of a Hypertension Digital Therapeutic in Medical Facilities Affects Patients' Healthcare Utilization' on Dec. 22.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - CureApp, Inc.
Condition:
Condition - Hypertension
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluate the impact of introducing the therapeutic SaMD (CureApp HT) on patient treatment behavior, specifically new visits and follow-up visits, at the healthcare institution implementing it.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
year...